Leading The Way In Pediatric Endo-Cannabinoid Medicine
Phyto Therapeutic Medicine for Inflammatory Conditions
Initial 2.2 Million Square Feet of Cultivation
Exclusive Clinically Validated Formulations
Innovation in Skin Care and Anti-Aging Systems
Relevium’s CEO Provides an Open Shareholder Letter for 2020
by Olga Tkach | December 19, 2019 | 2019 Press Releases | 0 Comments
MONTREAL, Dec. 19, 2019 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to provide an open letter to its shareholders from the company’s Chief Executive Officer, Aurelio...Relevium Launches LeefyLyfe™ Organic Hemp Products in the US
by Olga Tkach | November 20, 2019 | 2019 Press Releases | 0 Comments
MONTREAL, Nov. 20, 2019 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce the launch of LeefyLyfeTM Organics, a comprehensive line of organic health and wellness...Relevium Executes LOI to Acquire Montreal Biopharma Contract Manufacturing Company
by Olga Tkach | November 8, 2019 | 2019 Press Releases | 0 Comments
MONTREAL, Nov. 08, 2019 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce it has executed a letter of intent to acquire a Montreal based biopharma contract...Relevium Technologies
Relevium is a publicly traded corporation strategically focused on the expansion and acquisition of entrepreneurial brands within the health and wellness sector. Our focus is on being a trusted source of high-quality nutraceutical and CBD products.contact us
Relevium Technologies Inc.
1000 Sherbrooke West, Suite 2700
Montreal, QC, H3A 3G4
(888) 528-8687
www.releviumtechnologies.com
info@releviumtechnologies.com
trading information
Market data is delayed by 15 minutes
Relevium Provides Update to Management Cease Trade Order
by Olga Tkach | November 11, 2020 | 2020 Press Releases | 0 Comments
MONTREAL, Nov. 11, 2020 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTC: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”) is providing an update to its previously disclosed management cease trade order ("MCTO"), announced on October 27,...Relevium Announces Delay in Filing Annual Audited Financial Statements
by Olga Tkach | October 27, 2020 | 2020 Press Releases | 0 Comments
MONTREAL, Oct. 27, 2020 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTC: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”) announces that its annual financial statements for the year ended June 30, 2020, including the related management...Relevium Resumes Shipments for Overseas Contract and Delivers CAD $215,000 in Formulated Products to Saudi Arabia
by Olga Tkach | October 19, 2020 | 2020 Press Releases | 0 Comments
MONTREAL, Oct. 19, 2020 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce that the Company’s subsidiary, BGX E-Health LLC (“BGX”), has shipped a total of CAD...